Primary Peritoneal Carcinoma Active Not Recruiting Phase 1 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02661815A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological CancerTreatment